drugset
drugset / Trial / NCT05412992

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

NCT05412992 ↗

Phase 2 Terminated 179 enrolled Teikoku Pharma USA, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Timeline

Start
2022-07-07
Primary completion
2023-04-19
Completion
2023-04-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified — Other

Indications

No indication recorded.